German scientists have found success in reversing the plaque buildup in brains of mice. The plaque deposits are one of the hallmark features of Alzheimer’s disease (AD) and this finding may lead to viable treatments for humans.

The compound reportedly effectively blocks an enzyme responsible for development of the plaque. The compound attaches itself at the precise site on the cell wall where the toxic action occurs.

When injected directly into the brains of mice, scientists indicate the compound works well. The next step is to determine if the compound can cross the blood brain barrier, the protective shield around the brain. Animal tests have begun to determine if medicines given by mouth or injection have the high rate of efficacy as direct injection into the brain where there was a 50% reduction in plaque formation within four hours. Scientists believe that if the testing on animals goes well a human version could be available in five to ten years.